CMA
approves the Strategic Plan under the Private Healthcare Market Investigation
Order
The
Competition and Markets Authority has approved the Strategic Plan of the
Private Healthcare Information Network (PHIN) required by the Private
Healthcare Market Investigation Order 2014.
The
Order aims to address the adverse effects on competition that the CMA identified
in its final report on the private healthcare market investigation. The markets for private healthcare provision
and private healthcare insurance were the subject of a market investigation
reference in the UK (2012-2014). The
CMA’s final report concluded that certain features of the markets for
privately-funded healthcare services were leading to adverse effects on
competition. The CMA introduced a number
of remedies (including transparency remedies about private hospitals’
performance for patients and reduction in the incentives offered to referring
clinicians).
The
Order requires the establishment of an industry information organisation to
make private healthcare information (about private healthcare facilities and
consultants) available via an independent public website.
The
PHIN was approved for these purposes in 2014.
PHIN is required to submit to the CMA a five year plan, developed and
approved by its members setting out how it proposes to collect the information
specified in this Order and the basis on which it may licence access to the
information.
The
PHIN Strategic Plan outlines how the sector will deliver the remainder of the
requirements of the Order. The CMA
states that it will monitor progress closely and stands ready to take
enforcement action if hospitals or consultants fail to meet the standards and
timescales set out.
3Since
the final report, many of the competition and consumer welfare concerns
identified by the CMA as problematic if they were “extensively and rigidly
applied” have worsened and been applied by all the major private medical
insurers (PMIs). The consultants have
attempted to have the issues looked at afresh by the CMA, using a variety of
legal tools. These attempts have met
administrative priority objections.
However, while the original MIR was limited to a dataset on market
dynamics prevailing up to 2012 there does not appear to be appetite on the part
of the CMA to conduct another root and branch investigation.
https://www.gov.uk/cma-cases/private-healthcare-market-investigation